Related references
Note: Only part of the references are listed.Heart Disease and Stroke Statistics-2018 Update A Report From the American Heart Association
Emelia J. Benjamin et al.
CIRCULATION (2018)
International Validation of the Thrombolysis in Myocardial Infarction (TIMI) Risk Score for Secondary Prevention in Post-MI Patients: A Collaborative Analysis of the Chronic Kidney Disease Prognosis Consortium and the Risk Validation Scientific Committee
Yejin Mok et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2018)
PROGNOSTIC VALUE OF SLOX-1 LEVEL IN ACUTE CORONARY SYNDROMES BASED ON THROMBOLYSIS IN MYOCARDIAL INFARCTION RISK SCORE AND CLINICAL OUTCOME
Sina Mashayekhi et al.
JOURNAL OF EMERGENCY MEDICINE (2018)
Association of Endocan, Ischemia-Modified Albumin, and hsCRP Levels With Endothelial Dysfunction in Type 2 Diabetes Mellitus
Ilhan Balamir et al.
ANGIOLOGY (2018)
Admission Endocan Level may be a Useful Predictor for In-Hospital Mortality and Coronary Severity Index in Patients With ST-Segment Elevation Myocardial Infarction
Harun Kundi et al.
ANGIOLOGY (2017)
Serum Endothelial Cell-Specific Molecule 1 (Endocan) Levels in Patients With Acute Myocardial Infarction and Its Clinical Significance: A Pilot Study
Chong-Rong Qiu et al.
ANGIOLOGY (2017)
Endocan is a predictor of increased cardiovascular risk in women with polycystic ovary syndrome
Merve Bicer et al.
ENDOCRINE RESEARCH (2017)
β-Blockers and Mortality After Acute Myocardial Infarction in Patients Without Heart Failure or Ventricular Dysfunction
Tatendashe B. Dondo et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
Associations Between Psychological Constructs and Cardiac Biomarkers After Acute Coronary Syndrome
Christopher M. Celano et al.
PSYCHOSOMATIC MEDICINE (2017)
Feasibility of the Manchester Acute Coronary Syndromes (MACS) decision rule to safely reduce unnecessary hospital admissions: a pilot randomised controlled trial
Richard Body et al.
EMERGENCY MEDICINE JOURNAL (2017)
Endocan Levels and Subclinical Atherosclerosis in Patients With Systemic Lupus Erythematosus
Abdullah Icli et al.
ANGIOLOGY (2016)
Oxidative stress, inflammation, endothelial dysfunction and incidence of type 2 diabetes
Andrew O. Odegaard et al.
CARDIOVASCULAR DIABETOLOGY (2016)
Endothelial Cell Dysfunction and the Pathobiology of Atherosclerosis
Michael A. Gimbrone et al.
CIRCULATION RESEARCH (2016)
Serum Endocan Levels Are Correlated with the Presence and Severity of Coronary Artery Disease in Patients with Hypertension
Xiang-sheng Wang et al.
GENETIC TESTING AND MOLECULAR BIOMARKERS (2015)
Prognostic significance of transaminases after acute ST-elevation myocardial infarction: insights from a cardiac magnetic resonance study
Sebastian J. Reinstadler et al.
WIENER KLINISCHE WOCHENSCHRIFT (2015)
Serum Endocan Level and the Severity of Coronary Artery Disease: A Pilot Study
Murat Kose et al.
ANGIOLOGY (2015)
Endocan, a novel marker of endothelial dysfunction in patients with essential hypertension: Comparative effects of amlodipine and valsartan
Turgay Celik et al.
BLOOD PRESSURE (2015)
Endocan-A Novel Inflammatory Indicator in Newly Diagnosed Patients With Hypertension: A Pilot Study
Sevket Balta et al.
ANGIOLOGY (2014)
Serum endocan levels as a marker of disease activity in patients with Behcet disease
Ilknur Balta et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2014)
2014 AHA/ACC Guideline for the Management of Patients With Non-ST-Elevation Acute Coronary Syndromes: Executive Summary
Ezra A. Amsterdam et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
Plasma endocan levels associate with inflammation, vascular abnormalities, cardiovascular events, and survival in chronic kidney disease
Mahmut I. Yilmaz et al.
KIDNEY INTERNATIONAL (2014)
Clinical Correlates and Prognostic Value of Flow Mediated Dilation in Patients With Non-ST Segment Elevation Acute Coronary Syndromes
Giulia Careri et al.
AMERICAN JOURNAL OF CARDIOLOGY (2013)
Endothelial dysfunction over the course of coronary artery disease
Enrique Gutierrez et al.
EUROPEAN HEART JOURNAL (2013)
2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction: Executive Summary A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
Patrick T. O'Gara et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
Assessment of multiple cardiac biomarkers in non-ST-segment elevation acute coronary syndromes: observations from the MERLIN-TIMI 36 Trial
Benjamin M. Scirica et al.
EUROPEAN HEART JOURNAL (2011)
N-terminal pro-B-type natriuretic peptide is better than TIMI risk score at predicting death after acute myocardial infarction
S. Q. Khan et al.
HEART (2008)
Prognostic value of serum biomarkers in association with TIMI risk score for acute coronary syndromes
Euler R. F. Mantenti et al.
CLINICAL CARDIOLOGY (2006)
Mechanisms of disease - Inflammation, atherosclerosis, and coronary artery disease
GK Hansson
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Prognostic value of systemic endothelial dysfunction in patients with acute coronary syndromes - Further evidence for the existence of the vulnerable patient
S Fichtlscherer et al.
CIRCULATION (2004)
Impact of medical practice guidelines on the assessment of patients with acute coronary syndrome without persistent ST segment elevation
JB Wasserfallen et al.
INTERNATIONAL JOURNAL FOR QUALITY IN HEALTH CARE (2004)
Evaluation of B-type natriuretic peptide for risk assessment in unstable angina/non-ST-elevation myocardial infarttion - B-Type natriuretic peptide and prognosis in TACTICS-TIMI 18
DA Morrow et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2003)
TIMI risk score for ST-elevation myocardial infarction: A convenient, bedside, clinical score for risk assessment at presentation - An intravenous nPA for treatment of infarcting myocardium early II trial substudy
DA Morrow et al.
CIRCULATION (2000)
Characterization of the secreted form of endothelial-cell-specific molecule 1 by specific monoclonal antibodies
D Bechard et al.
JOURNAL OF VASCULAR RESEARCH (2000)
The TIMI risk score for unstable angina/non-ST elevation MI - A method for prognostication and therapeutic decision making
EM Antman et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2000)
Share Paper
